Market expansion opportunities The Stork OTC is FDA-cleared for at-home conception and is already positioned in the US, UK, and Australia with growing retailer availability. Target expanding markets with gynecology clinics, fertility centers, and direct-to-consumer channels in additional regions to accelerate adoption and drive recurring sales.

Retail scaling potential With presence in almost 5,000 retail locations nationwide via recent launches, there is room to leverage partnerships with major retail chains and pharmacy networks to broaden shelf space, drive impulse purchases, and increase consumer trial rates.

Clinical credibility FDA clearance and published clinical data demonstrating higher sperm delivery efficiency bolster validation when engaging healthcare providers, fertility clinics, and patient advocacy groups to recommend The Stork OTC as a trusted home-use option.

Cross-sell strategies A women’s health portfolio approach can be pursued by bundling The Stork OTC with complementary fertility products or services, such as ovulation tracking, fertility counseling, or related diagnostic tools, to increase average order value and lifetime customer value.

Funding and growth leverage With substantial funding and modest current revenue, there is an opportunity to fund direct sales expansion, channel marketing, and regional partnerships; emphasize scalable D2C and retailer-led campaigns to accelerate revenue generation and market share.